Literature DB >> 23765560

Influence of red algal sulfated polysaccharides on blood coagulation and platelets activation in vitro.

Ekaterina V Sokolova1, Anna O Byankina, Alexandra A Kalitnik, Yong H Kim, Larisa N Bogdanovich, Tamara F Solov'eva, Irina M Yermak.   

Abstract

The influence of sulfated polysaccharides (λ-, κ-, and κ/β-carrageenan and porphyran) - on platelet activation was studied. Carrageenans were much weaker inhibitors of a coagulation process than heparin, while porphyran had not that effect. Results of the aPTT and PT assays suppose that carrageenans affected mostly intrinsic pathway of coagulation, while their effect on the extrinsic pathway is extremely low (λ and κ/β) or absent (κ, LMW derivative of κ-carrageenan). λ-Carrageenan was the most potent anticoagulant agent in TT, aPTT, PT, and anti-factor Xa activity. This sample was also the strongest inhibitor of collagen-induced platelet aggregation in PRP. Generally, the correlation of anticoagulant and antithrombotic action in PRP is preserved for carrageenans but not for heparin. Carrageenans and porphyran affected platelet adhesion to collagen by influencing glycoprotein VI. Low molecular weight κ-carrageenan had a similar effect on platelet adhesion mediated with both major collagen receptors: integrin α2 β1 and glycoprotein VI as native polysaccharide had. Carrageenans resulted in activation of platelets under platelet adhesion mediated by integrin αIIb β3 with less degree than heparin. The least sulfated κ/β-carrageenan that possessed an inhibiting effect on thrombin- and collagen-induced aggregation of washed platelets and on the PT test but it had no significant effect on TT was the weakest promoter of integrin αIIb β3 mediated platelet activation. In summary, our study showed that the polysaccharide action was complex, since it depended on its molecular mass, sulfation degree, and monosaccharide contents (3,6-anhydrogalactose).
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  carrageenan; coagulation; platelet adhesion/aggregation; porphyran; red blood cells

Mesh:

Substances:

Year:  2013        PMID: 23765560     DOI: 10.1002/jbm.a.34827

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  6 in total

1.  Characterization and Comparison of the Structural Features, Immune-Modulatory and Anti-Avian Influenza Virus Activities Conferred by Three Algal Sulfated Polysaccharides.

Authors:  Lin Song; Xiaolin Chen; Xiaodong Liu; Fubo Zhang; Linfeng Hu; Yang Yue; Kecheng Li; Pengcheng Li
Journal:  Mar Drugs       Date:  2015-12-29       Impact factor: 5.118

Review 2.  Algal Polysaccharides as Therapeutic Agents for Atherosclerosis.

Authors:  Nikita P Patil; Victoria Le; Andrew D Sligar; Lei Mei; Daniel Chavarria; Emily Y Yang; Aaron B Baker
Journal:  Front Cardiovasc Med       Date:  2018-10-26

Review 3.  Progress in Modern Marine Biomaterials Research.

Authors:  Yuliya Khrunyk; Slawomir Lach; Iaroslav Petrenko; Hermann Ehrlich
Journal:  Mar Drugs       Date:  2020-11-25       Impact factor: 5.118

Review 4.  Hydrogel-Forming Algae Polysaccharides: From Seaweed to Biomedical Applications.

Authors:  Marco Beaumont; Remy Tran; Grace Vera; Dennis Niedrist; Aurelie Rousset; Ronan Pierre; V Prasad Shastri; Aurelien Forget
Journal:  Biomacromolecules       Date:  2021-02-12       Impact factor: 6.978

5.  Chemical Structure and Anticoagulant Property of a Novel Sulfated Polysaccharide from the Green Alga Cladophora oligoclada.

Authors:  Meijia He; Yajing Yang; Zhuling Shao; Junyan Zhang; Changning Feng; Lei Wang; Wenjun Mao
Journal:  Mar Drugs       Date:  2021-09-29       Impact factor: 5.118

6.  The Comparative Immunotropic Activity of Carrageenan, Chitosan and Their Complexes.

Authors:  Viktoriya N Davydova; Irina V Sorokina; Aleksandra V Volod'ko; Ekaterina V Sokolova; Marina S Borisova; Irina M Yermak
Journal:  Mar Drugs       Date:  2020-09-04       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.